Navigation Links
Old drug shows new promise for Huntington's Disease

n water. After eight weeks of treatment, they had accumulated four times less toxic protein in their brains than control mice given water alone. The experimental animals lived 20 percent longer than the control animals, did better on tests of motor coordination, and had less weight loss.

"It's a limited study, in that we used the same drug dose on all the animals as opposed to comparing different doses, but fairly convincing," Massa concluded. "Together, the in vitro and in vivo results suggest that Clioquinol has an effect of decreasing the symptoms of Huntington's, its pathology, and perhaps even the actual production of the toxic protein."

However, he noted, "the drug's mechanism of action remains unclear." The clearer the mechanism of the drug, he explained, the better the chance that researchers might eventually be able to create a medication that is both safe and effective.

Like some other antibiotics, Clioquinol is known to be a chelator -- that is, it binds metals in body tissues, particularly copper and zinc, and removes them when it is excreted. Massa and other researchers believe that this chelation effect may interfere with production of the mutant huntingtin protein in some way. "But there are still a couple of explanations we need to rule out," he said.

To that end, Massa's next studies will involve the creation of an in vitro system in which toxic and non-toxic forms of huntingtin are made in the same cell. He and his team will then evaluate the effects of Clioquinol on several phases of protein synthesis within the cell. Massa hopes these experiments will confirm initial indications that Clioquinol preferentially interferes with synthesis of the toxic form of the protein. "Then we can move on to trying to isolate the actual mechanism of the drug," he predicted.

"However," Massa cautioned, "the record of successfully translating drugs from animal to human use is not good."

Clioquinol has shown promise a
'"/>

Source:University of California - San Francisco


Page: 1 2 3

Related biology news :

1. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
2. “Nano-scissors?laser shows precise surgical capability
3. Clam embryo study shows pollutant mixture adversely affects nerve cell development
4. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
5. Study shows nanoshells ideal as chemical nanosensors
6. Gene vaccine for Alzheimers disease shows promising results
7. Flocking together: Study shows how animal groups find their way
8. New drug shows promise as powerful anticancer agent
9. Loves all in the brain: fMRI study shows strong, lateralized reward, not sex, drive
10. Test for early detection of prostate cancer shows promise
11. Mouse gene shows new mechanism behind cardiac infarction in man
Post Your Comments:
(Date:12/15/2009)... This release is available in German ... laws everywhere across the globe, cultures vary as to ... example, do not use egocentric terms such as ,left, ... using allocentric notions like ,north, south, east, west, at ... of the bowl" or "There is an snake by ...
(Date:12/15/2009)... . , Leipzig: Species distribution models are of only ... This is the finding of a study of the ... analysed data on species distribution, climate, land cover and ... species. Judging by the large differences in climate niches ... fast to changing climatic conditions. This in turn makes ...
(Date:12/15/2009)... exact an enormous emotional and economic toll on society. ... rip currents each year in U.S. waters and it,s likely ... worldwide. A serious disconnect exists between rip current research ... rip tides and undertows, and more importantly, most people do ... a rip current. , The goal of the Rip Current ...
Breaking Biology News(10 mins):More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2Sagent Pharmaceuticals to Present at Piper Jaffray Health Care Conference 6454 1Neurobiological Technologies Announces Extraordinary Dividend of 240 18 per Share 6451 1Neurobiological Technologies Announces Extraordinary Dividend of 240 18 per Share 6451 2DopeStats com Provides Statistics on Oxycodone Abused in Non Medical Purposes 61912 1DopeStats com Provides Statistics on Oxycodone Abused in Non Medical Purposes 61912 2
... events throughout the world, resulting in large-scale ecosystem alteration ... of drought vary from year to year in severity ... to more severe conditions. Many modern varieties of ... and cultivation in the cold, dry Andean Altiplano gave ...
... Two Montana state University researchers are principal editors on ... ways to study carnivores in the wild. , "Noninvasive ... June 27 with Robert Long and Paula MacKay as ... Western Transportation Institute. , Working with two co-editors ...
... is at the heart of many eco-friendly efforts, and ... nature has been lending a hand. Researchers at the ... discovered that trees submerged in freshwater aquatic systems store ... of time than trees that fall in a forest, ...
Other Biology News:Drought tolerance in potatoes 2Drought tolerance in potatoes 3Ancient oak trees help reduce global warming 2
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 The International ... that the professional society is continuing to accept ... being held in Arlington, VA, April 19-21, 2010. ... is encouraging non-members to join the organization to ... The submission deadline is 12 AM EST, January ...
(Date:12/15/2009)... Thomson Reuters ... become the first drug pipeline database to fully ... This highly anticipated new content is being provided ... ,, Thomson Pharma will offer ... press releases, conferences, and other sources across all ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Mass., Jan. 28 Joseph F. Finn, Jr.,CPA, the ... the completion the sale of the Company,s fixed assets ... 24th. In addition, due to,the high volume of requests ... of the intellectual property, the Company has,created an online ...
... Jan. 28 Carl Icahn confirmed today that,entities affiliated ... they,intend to nominate three persons at Biogen,s forthcoming 2008 ... Biogen currently,has a staggered board of twelve directors, and ... Mr. Icahn stated that "We are taking this action ...
... a Human Capillary, DUBLIN, Ireland, Jan. ... microfluidic systems in the emerging field of,nano-lifesciences, ... VenaFlux(TM),Platform. The VenaFlux(TM), the first semi-automated, high ... adhesion to,antibody-coated or endothelial- cell cultured microchannels, ...
Other Biology Technology:Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform 2
... The FRT-amp-FRT cassette is designed ... The prokaryotic promoter gb2 driving the ... modified version of the Em7 promoter. It ... used Tn5 promoter. A synthetic polyadenylation signal ...
... S-7 stirrers deliver accurate and ... fluids away from internal components. ... controls which allow users to ... tops feature a chemical resistant, ...
... loxP-cm-loxP cassette is designed ... cells. The prokaryotic promoter gb2 ... is a slightly modified version of ... transcription efficiency than the generally used ...
... This kit is designed for the fast ... vector plasmids at any position (for the ... loxP-PGK-gb2-neo-loxP cassette is designed to allow neomycin ... cells. It combines a prokaryotic promoter (gb2) ...
Biology Products: